6. Stryker Corporation (NYSE:SYK)
Stryker Corporation (NYSE: SYK) enters the ranking through one of the most commercially proven areas of robotics: robotic-assisted orthopedic surgery. Its Mako system helps surgeons plan and perform hip and knee procedures using patient-specific data and a robotic arm. The system does not replace the surgeon. Instead, it assists with planning, positioning, and controlled bone preparation during complex operations.
The healthcare setting gives Stryker Corporation (NYSE: SYK) an attractive business model. A hospital’s investment in a robotic system can encourage continued use of the company’s implants, instruments, software, and related services. That creates an ecosystem around the machine rather than a one-time equipment sale. As populations age and demand for joint-replacement procedures increases, robotic-assisted surgery could become a larger part of orthopedic care.
Stryker Corporation (NYSE: SYK) reported second-quarter 2026 sales of approximately $6.6 billion, representing reported growth of 9.4% and organic growth of 9%. Orthopaedics sales rose 9.1%, supported by higher unit volumes and continued adoption of robotic-assisted procedures. Competition in medical robotics is intensifying, and hospitals must justify the cost of expensive surgical platforms. Nevertheless, Stryker Corporation (NYSE: SYK) combines a profitable medical-technology business with an established robotic platform, making it a more financially grounded choice than early-stage surgical robotics stocks that have yet to achieve large-scale adoption.
YOU MUST READ THIS: Top 10 Best Stock Picks With Possible 500% Upside
Click here to continue reading and checkout the 5 Best Robotics Stocks to Buy Before the Robot Revolution Takes Off.
Disclosure: No material interests to disclose. This article was originally published on Global Market Bulletin.
